NRPR 09/24/07 : NPRI Receives Kosher Certification for Family of O2P Powders
September 24, 2007 - 9:09 AM EDT
Nutri Pharmaceuticals Research Inc. (Pink Sheets: NRPR), a leading developer and marketer of powdered nutritional ingredients, announces it has again received renewal of its Kosher certification for the company’s O2P™ family of oil powders.
Kosher certification guarantees that both the ingredients and manufacturing equipment used to produce O2P™ Powders meet the stringent requirements of “Kashrus” or Jewish dietary laws.
According to NPRI president and CEO, Godfrey Yew, “Maintaining our Kosher certification is important for the present and future growth of our company. Kosher certification is further proof of our commitment to providing the highest quality, purity and consistency in our O2P powdered oils to the food and nutraceutical industries.”
Certification was provided by OK Kosher Certification, whose “OK” is among the world’s most respected kosher symbols, establishing the standards for kosher in the United States, Europe and the Orient.
Copies of the certifications are on file and available upon request.
About NRPR:
Nutri Pharmaceuticals Research Inc. (www.o2pus.com) provides a wide range of powdered oils for functional food, food supplement; pharmaceutical; cosmetic; pet food and animal feed applications.
The company is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2P™ Powderization process. At the heart of its oil powders is the O2P™ Oil-to-Powder technology. This patent-pending process converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P™ does not rely on traditional techniques that utilize extremes in heat or cold, micro-encapsulation or nanotechnology. This facilitates food marketing and supplement producers' ability to create functional foods and nutraceuticals by adding anti-oxidants, specific EFAs, or other fatty acids such as EPA, GLA, DHA, and CLA to assist in maintaining specific health issues.
The company currently offers more than 50 shelf-stable powders. The company can also apply O2P™ technology to a third-party's oil, paste or gel through an arrangement called tolling. Based in Las Vegas, the company has representative sales offices near Chicago, Amsterdam, Guatemala City and Bangkok.
Nutri Pharmaceuticals Research Inc. shares are currently traded in the United States on the "Pinksheets" under the symbol NRPR.PK.
Nutri Pharmaceuticals Research Inc., Las Vegas
Godfrey Yew, 702-309-8627
E-mail: godfrey@o2pus.com
or
Princeton Research, Inc
Mike King, 702-650-3000
mike@princetonresearch.com
Source: Business Wire (September 24, 2007 - 9:09 AM EDT)
News by QuoteMedia
www.quotemedia.com
DIVERSIFICATION IS RULE #1 -- YOU ALONE ARE RESPONSIBLE FOR YOUR INVESTMENT DECISIONS -- ALWAYS CONDUCT YOUR OWN DUE DILIGENCE -- NEVER INVEST MORE THAN YOU CAN AFFORD TO LOSE -- HOPE IS NOT AN INVESTMENT STRATEGY -- PATIENCE !!!
